Patents Assigned to Baltech, Inc.
  • Treatment of virus infections with ganglionic blocking agents
    Patent number: 5686448
    Abstract: A method for preventing or treating infection or disease in a mammal caused by a virus, such as herpes simplex virus type 1 and 2. A ganglionic blocking agent, such as tetraethylammonium ion or hexamethonium ions, is administered to the mammal in an effective dosage.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 11, 1997
    Assignee: Baltech, Inc.
    Inventor: Joseph A. Baldone
  • Treatment of diseases caused by herpes viruses
    Patent number: 5158980
    Abstract: This invention pertains to a method of treating diseases caused by Herpes Simplex Virus (HSV) Types 1 and 2. Disclosed herein is a method of treatment that, through the use of Tetraethylammonium Ion (TEA) achieves a selective and specific inhibition of viral function in diseases caused by HSV Types 1 and 2. TEA can be provided in the form of its chloride salt, unpreserved for individual doese, or with preservatives for multiple dose vials.
    Type: Grant
    Filed: September 26, 1991
    Date of Patent: October 27, 1992
    Assignee: Baltech, Inc.
    Inventor: Joseph A. Baldone
  • Treatment of diseases caused by herpes viruses
    Patent number: 4760079
    Abstract: This invention pertains to a method of treating diseases caused by Herpes Simplex Virus (HSV) Types 1 and 2. Disclosed herein is a method of treatment that, through the use of Tetraethylammonium Ion (TEA) achieves a selective and specific inhibition of viral function in diseases caused by HSV Types 1 and 2. TEA can be provided in the form of its chloride salt, unpreserved for individual doses, or with preservatives for multiple dose vials.
    Type: Grant
    Filed: August 4, 1987
    Date of Patent: July 26, 1988
    Assignee: Baltech, Inc.
    Inventor: Joseph A. Baldone